TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean intimal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Grafts with significant stenosis percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum triacylglycerols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total response rate
Endpoint domain: Adverse events/effects
Primary endpoint: Serum LDL-cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hand bacterial counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M72-specific CD4(+) T-cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Humoral responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety profile with no vaccine-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: overall elasticity values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Joint surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean survival time until the first surgical intervention
Endpoint domain: Mortality/survival
Primary endpoint: Rates of unprotected sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MVCOLQ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of fentanyl-induced cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: splanchnic perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of acute rejection episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Intraoperative haemodynamic stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Need for analgesia in recovery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cutaneous take reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: humoral immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: adverse events related to vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in negative beliefs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Trauma-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: control over heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reduced severity of CHF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of Paroxysmal Atrial Fibrillation (PAF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: C-reactive protein (CRP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: sensitivity of the PP method for detecting ACO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: specificity of the PP method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: median number of leads per patient demonstrating ECG changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Development of cardiac allograft vasculopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction with the ACP-I Plan intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 10-year cumulative probability of graft failure
Endpoint domain: Mortality/survival
Primary endpoint: adoption of a low‐fat diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stage of change for fruit and vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acetaminophen consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patients' global assessment improvement rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physician's global assessment improvement rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Good recovery rate of thrombocytopenia (GOS score 4-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: vertebral fracture risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: nonvertebral fracture risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: all clinical fractures risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Binary in-segment restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mortality of cor-pulmonale
Endpoint domain: Mortality/survival
Primary endpoint: Rate of quitting smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FEV1 decrement per capita yearly
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PFS-6 rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodialysis requirement after liver transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative creatinine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Aldosterone level suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Severity of Alopecia Tool (SALT) score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean standing systolic blood-pressure change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean dizziness/lightheadedness score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of reported falls
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of NBI for diagnosis of superficial cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of NBI for diagnosis of superficial cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline on the Mini-Mental State Exam
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in LDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in HDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in Lp-PLA2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of increase in ST depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal ST depression at longest equivalent sub‐maximal exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Arterial pressure response to salt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum Walking Time (MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of binge drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-monitoring
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: number of individual care plans
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mean number of metastatic lymph nodes harvested
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Full opiate receptor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications related to detoxification procedure or general anesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of PND in 'at risk' women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ward round competence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: muscle reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: reaction duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Average time of stone expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Average dose of analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year regional control
Endpoint domain: Mortality/survival
Primary endpoint: metastases-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Cocaine withdrawal symptoms reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug use severity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-operative expenses
Endpoint domain: Resource use
Primary endpoint: Plasma levels of TNF-alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma levels of MCP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma levels of MIP-1beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mortality and nonfatal myocardial infarction within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative risk of second malignancies
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative risk of acute non-lymphocytic leukemia
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of myopia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of free glasses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Experience of using the pack
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pack attributes rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact of health warning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subphenotype signatures of lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HSV-2 incidence rate
Endpoint domain: Mortality/survival
Primary endpoint: HSV-2 seroconversions
Endpoint domain: Mortality/survival
Primary endpoint: time to virologic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to safety events
Endpoint domain: Adverse events/effects
Primary endpoint: time to tolerability events
Endpoint domain: Adverse events/effects
Primary endpoint: recovery of upper limb motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PD20 AMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in plasma concentrations of cytokines and metabolic markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clearance of 99mTc-DTPA from the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Urinary AER
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean steps/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality Adjusted Life Year
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Absenteeism
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in isoflurane requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic response control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major Adverse Cardiovascular Events (MACEs)
Endpoint domain: Mortality/survival
Primary endpoint: Net Adverse Clinical Events (NACEs)
Endpoint domain: Mortality/survival
Primary endpoint: Pain experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Need for pain relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete clearance at day 42
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of fracture union
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Spasticity score for the ankle plantar flexor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neointimal Hyperplasia (NIH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Wall Shear Stress (WSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: change in FEV1 at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in ACQ score at 18 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concentration difficulty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: irritability or anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute Mountain Sickness (AMS) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of health service providers identified for further action
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tendency to request further information
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: discretionary food intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median soft tissue thickness increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEAV of median nerve sensory blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative mortality
Endpoint domain: Mortality/survival
Primary endpoint: inattention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hyperactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body composition reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to normalization of plasma lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in clinical severity scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incremental gain in QALYs per person
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean incremental cost per QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Spine BMD increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip BMD increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in vertebral fracture risk
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in non-vertebral fracture risk
Endpoint domain: Adverse events/effects
Primary endpoint: median time to full expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ease of use rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: soluble CD40 ligand levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ovarian cancer risk
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients free of panic attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative atelectasis area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Readmission for a COPD exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in IES-R total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in CGI-S score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of responders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean pleural fluid sIL-2R concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Meaningful changes in patient's quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time until beginning feedings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of abdominal radiographs required
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of aspiration
Endpoint domain: Adverse events/effects
Primary endpoint: anal resting pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of children with antibody concentrations ≥0.2 µg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of children with opsonophagocytic activity titres ≥8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: AAV relapse rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total cardiovascular risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: median disease-specific survival
Endpoint domain: Mortality/survival
Primary endpoint: Hospitalization rates
Endpoint domain: Mortality/survival
Primary endpoint: Iron need for erythropoiesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of major predefined cardiac adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: proportion of tachycardia termination within 40 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: anterior chamber depth variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean spherical equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deviation from intended versus achieved capsulotomy area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Levels of pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impaired speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impaired swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in knee osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of successful PTN block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median latency to complete block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite physical domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oropharyngeal colonization by pathogenic Gram-negative bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Risk of pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Uterine atony
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer-related fatigue (CRF)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Time to bone union
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Inappropriate shocks
Endpoint domain: Adverse events/effects
Primary endpoint: Likelihood of nicotine withdrawal syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success in quit attempts
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: plasma concentration of flavanols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: 24-h urine concentration of γ‐VLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation dose estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic image quality scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hsC-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: UKPDS 10 years risk of coronary heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes